July 23: India’s pharmaceutical market is entering a period of global trade transition with strong support from domestic growth, according to a recent report. The sector continues to demonstrate resilience amid changing international tariff conditions and evolving market dynamics.
The report highlighted that India’s pharmaceutical industry is being supported by rising domestic demand, increasing healthcare awareness, expanding access to medicines, and steady growth across key therapeutic segments.
While global trade policies, including changes in tariff structures, may create challenges for pharmaceutical exporters, the industry’s strong domestic foundation is expected to provide stability and support continued expansion.
India’s pharma sector remains a major contributor to the global healthcare ecosystem, with the country playing a significant role in medicine production and supply chains worldwide. Companies are focusing on innovation, manufacturing capabilities, and market diversification to navigate changing global conditions.
Industry experts said strengthening research and development, improving manufacturing standards, and expanding healthcare access will remain important factors for sustaining long-term growth.
The report noted that India’s pharmaceutical market is well-positioned to manage external uncertainties while continuing its growth trajectory through domestic demand and global opportunities.
